JESSE RIVERA: Open Payments
NPI 1821659202 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 13 payments from 8 companies in 2025. Trend: 2023 $479 · 2024 $285 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Edwards Lifesciences Corporation | 2 | $58 |
| Alnylam Pharmaceuticals Inc. | 1 | $30 |
| Medtronic, Inc. | 2 | $27 |
| Boston Scientific Corporation | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Amgen Inc. | 1 | $16 |
Products named: LEQVIO, AMVUTTRA, ENDURANT IIS, ENTRESTO, WATCHMAN FLX, VERQUVO, Kerendia, REPATHA.
Industry payments across TX — which companies pay providers there.
